Boston Scientific (BSX) Net Margin (2009 - 2026)
Boston Scientific recorded quarterly Net Margin of 25.77% in Q1 2026, up 102.74% quarter-over-quarter from 12.71% in Q4 2025, and up 1132.0% year-over-year from 2.09% in Q1 2025.
Boston Scientific's Net Margin history runs 18 years deep, the most recent figure standing at 25.77% for Q1 2026.
- In Q1 2026, Net Margin rose 1132.0% year-over-year to 25.77%; the TTM figure through Mar 2026 stood at 17.29% (up 572.0% YoY), while the FY2025 annual figure was 14.44%, up 337.0% from the prior year.
- Net Margin came in at 25.77% for Q1 2026 at Boston Scientific, up from 12.71% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 25.77% in Q1 2026 to a low of 3.21% in Q1 2022.
- A 5-year average of 11.29% and a median of 12.39% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin plunged 868 bps in 2022 and surged 1132 bps in 2026, its largest moves.
- Boston Scientific's Net Margin stood at 3.89% in 2022, then surged by 249 bps to 13.56% in 2023, then decreased by 9 bps to 12.39% in 2024, then advanced by 3 bps to 12.71% in 2025, then jumped by 103 bps to 25.77% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 25.77%, 12.71%, and 14.91% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 11.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.77% |
| Dec 31, 2025 | 12.71% |
| Sep 30, 2025 | 14.91% |
| Jun 30, 2025 | 15.75% |
| Mar 31, 2025 | 14.45% |
| Dec 31, 2024 | 12.39% |
| Sep 30, 2024 | 11.14% |
| Jun 30, 2024 | 7.86% |
| Mar 31, 2024 | 12.84% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | 14.32% |
| Jun 30, 2023 | 7.25% |
| Mar 31, 2023 | 8.85% |
| Dec 31, 2022 | 3.89% |
| Sep 30, 2022 | 5.49% |
| Jun 30, 2022 | 7.58% |
| Mar 31, 2022 | 3.21% |
| Dec 31, 2021 | 2.56% |
| Sep 30, 2021 | 13.81% |
| Jun 30, 2021 | 5.59% |
| Mar 31, 2021 | 11.88% |
| Dec 31, 2020 | 7.24% |
| Sep 30, 2020 | -6.36% |
| Jun 30, 2020 | -7.64% |
| Mar 31, 2020 | 0.43% |
| Dec 31, 2019 | 137.60% |
| Sep 30, 2019 | 4.65% |
| Jun 30, 2019 | 5.85% |
| Mar 31, 2019 | 17.01% |
| Dec 31, 2018 | 15.07% |
| Sep 30, 2018 | 18.05% |
| Jun 30, 2018 | 22.33% |
| Mar 31, 2018 | 12.48% |
| Dec 31, 2017 | -25.50% |
| Sep 30, 2017 | 12.74% |
| Jun 30, 2017 | 6.47% |
| Mar 31, 2017 | 13.43% |
| Dec 31, 2016 | 5.66% |
| Sep 30, 2016 | 10.83% |
| Jun 30, 2016 | -9.74% |
| Mar 31, 2016 | 10.29% |
| Dec 31, 2015 | -7.18% |
| Sep 30, 2015 | -10.49% |
| Jun 30, 2015 | 5.53% |
| Mar 31, 2015 | -0.06% |
| Dec 31, 2014 | -15.85% |
| Sep 30, 2014 | 2.33% |
| Jun 30, 2014 | 0.21% |
| Mar 31, 2014 | 7.50% |
| Dec 31, 2013 | 5.88% |
| Sep 30, 2013 | -0.29% |
| Jun 30, 2013 | 7.19% |
| Mar 31, 2013 | -20.10% |
| Dec 31, 2012 | 3.35% |
| Sep 30, 2012 | -38.27% |
| Jun 30, 2012 | -195.73% |
| Mar 31, 2012 | 6.06% |
| Dec 31, 2011 | 5.79% |
| Sep 30, 2011 | 7.58% |
| Jun 30, 2011 | 7.39% |
| Mar 31, 2011 | 2.39% |
| Dec 31, 2010 | 11.79% |
| Sep 30, 2010 | 9.92% |
| Jun 30, 2010 | 5.08% |
| Mar 31, 2010 | -81.07% |
| Dec 31, 2009 | -51.76% |
| Sep 30, 2009 | -4.64% |
| Jun 30, 2009 | 7.62% |
| Mar 31, 2009 | -0.65% |